Skip to main content
Top
Published in: Journal of Clinical Immunology 1/2019

01-01-2019 | Neutropenia | Original Article

Mosaicism of an ELANE Mutation in an Asymptomatic Mother

Authors: Tomonari Shigemura, Norimoto Kobayashi, Kazunaga Agematsu, Osamu Ohara, Yozo Nakazawa

Published in: Journal of Clinical Immunology | Issue 1/2019

Login to get access

Abstract

Purpose

We report normal neutrophil count in a mother, who carries the same ELANE mutation as her daughter with severe congenital neutropenia. We hypothesized that the mother possessed wild- and mutant-type clones and the wild-type clones could generate neutrophils, whereas the mutant clones could not.

Methods

We confirmed mutant variant ratio by sequence signals and measured the frequency of the mutant allele by subcloning in various cell types. We established the ELANE-mutated and non-mutated induced pluripotent stem cells (iPSCs) from the mother’s T cells and compared granulopoiesis between these iPSCs.

Results

In the sequence analysis of isolated peripheral blood (PB), nail and hair, the mutant variant was detected in approximately 40–60% of lymphocytes, monocytes, hematopoietic progenitor cells, and hair as well as in a small percentage of nail, but in none of the neutrophils. In the subcloning analysis of extracted DNA from CD3+ and CD34+ cells, the mutant allele was identified in 37.5% and 38.1%, respectively. We reprogrammed the mother’s PB cells and established the ELANE-mutated and non-mutated iPSCs. Granulopoiesis from mutated iPSCs revealed little sensitivity to granulocyte colony-stimulating factor in comparison with non-mutated iPSCs.

Conclusions

These observations strongly suggest that mutant-carrying neutrophils did not appear in the mother’s PB because mutated clones could not differentiate into neutrophils. The mother’s normal hematological phenotype could be explained by the perseverance of normal, non-mutated granulopoiesis.
Literature
1.
go back to reference Welte K, Dale D. Pathophysiology and treatment of severe chronic neutropenia. Ann Hematol. 1996;72:158–65.CrossRefPubMed Welte K, Dale D. Pathophysiology and treatment of severe chronic neutropenia. Ann Hematol. 1996;72:158–65.CrossRefPubMed
2.
go back to reference Dale DC, Person RE, Bolyard AA, Aprikyan AG, Bos C, Bonilla MA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood. 2000;96:2317–22.PubMed Dale DC, Person RE, Bolyard AA, Aprikyan AG, Bos C, Bonilla MA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood. 2000;96:2317–22.PubMed
3.
go back to reference Boxer LA, Newburger PE. A molecular classification of congenital neutropenia syndromes. Pediatr Blood Cancer. 2007;49:609–14.CrossRefPubMed Boxer LA, Newburger PE. A molecular classification of congenital neutropenia syndromes. Pediatr Blood Cancer. 2007;49:609–14.CrossRefPubMed
4.
go back to reference Bellanne-Chantelot C, Clauin S, Leblanc T, Cassinat B, Rodrigues-Lima F, Beaufils S, et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French neutropenia register. Blood. 2004;103:4119–25.CrossRefPubMed Bellanne-Chantelot C, Clauin S, Leblanc T, Cassinat B, Rodrigues-Lima F, Beaufils S, et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French neutropenia register. Blood. 2004;103:4119–25.CrossRefPubMed
5.
go back to reference Rosenberg PS, Alter BP, Link DC, Stein S, Rodger E, Bolyard AA, et al. Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia. Br J Haematol. 2008;140:210–3.PubMed Rosenberg PS, Alter BP, Link DC, Stein S, Rodger E, Bolyard AA, et al. Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia. Br J Haematol. 2008;140:210–3.PubMed
6.
go back to reference Briars GL, Parry HF, Ansari BM. Dominantly inherited severe congenital neutropenia. J Inf Secur. 1996;33:123–6. Briars GL, Parry HF, Ansari BM. Dominantly inherited severe congenital neutropenia. J Inf Secur. 1996;33:123–6.
7.
go back to reference Boxer LA, Stein S, Buckley D, Bolyard AA, Dale DC. Strong evidence for autosomal dominant inheritance of severe congenital neutropenia associated with ELA2 mutations. J Pediatr. 2006;148:633–6.CrossRefPubMed Boxer LA, Stein S, Buckley D, Bolyard AA, Dale DC. Strong evidence for autosomal dominant inheritance of severe congenital neutropenia associated with ELA2 mutations. J Pediatr. 2006;148:633–6.CrossRefPubMed
8.
go back to reference Kollner I, Sodeik B, Schreek S, Heyn H, von Neuhoff N, Germeshausen M, et al. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood. 2006;108:493–500.CrossRefPubMed Kollner I, Sodeik B, Schreek S, Heyn H, von Neuhoff N, Germeshausen M, et al. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood. 2006;108:493–500.CrossRefPubMed
9.
go back to reference Tidwell T, Wechsler J, Nayak RC, Trump L, Salipante SJ, Cheng JC, et al. Neutropenia-associated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoforms. Blood. 2014;123:562–9.CrossRefPubMedPubMedCentral Tidwell T, Wechsler J, Nayak RC, Trump L, Salipante SJ, Cheng JC, et al. Neutropenia-associated ELANE mutations disrupting translation initiation produce novel neutrophil elastase isoforms. Blood. 2014;123:562–9.CrossRefPubMedPubMedCentral
10.
go back to reference Newburger PE, Pindyck TN, Zhu Z, Bolyard AA, Aprikyan AAG, Dale DC, et al. Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes. Pediatr Blood Cancer. 2010;55:314–7.CrossRefPubMedPubMedCentral Newburger PE, Pindyck TN, Zhu Z, Bolyard AA, Aprikyan AAG, Dale DC, et al. Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes. Pediatr Blood Cancer. 2010;55:314–7.CrossRefPubMedPubMedCentral
11.
go back to reference Sakashita K, Kato I, Daifu T, Saida S, Hiramatsu H, Nishinaka Y, et al. In vitro expansion of CD34(+)CD38(−) cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia. Leukemia. 2015;29:606–14.CrossRefPubMed Sakashita K, Kato I, Daifu T, Saida S, Hiramatsu H, Nishinaka Y, et al. In vitro expansion of CD34(+)CD38(−) cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia. Leukemia. 2015;29:606–14.CrossRefPubMed
12.
go back to reference Seki T, Yuasa S, Oda M, Egashira T, Yae K, Kusumoto D, et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell. 2010;7:11–4.CrossRefPubMed Seki T, Yuasa S, Oda M, Egashira T, Yae K, Kusumoto D, et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell. 2010;7:11–4.CrossRefPubMed
13.
go back to reference Ma F, Wang D, Hanada S, Ebihara Y, Kawasaki H, Zaike Y, et al. Novel method for efficient production of multipotential hematopoietic progenitors from human embryonic stem cells. Int J Hematol. 2007;85:371–9.CrossRefPubMed Ma F, Wang D, Hanada S, Ebihara Y, Kawasaki H, Zaike Y, et al. Novel method for efficient production of multipotential hematopoietic progenitors from human embryonic stem cells. Int J Hematol. 2007;85:371–9.CrossRefPubMed
14.
go back to reference Hiramoto T, Ebihara Y, Mizoguchi Y, Nakamura K, Yamaguchi K, Ueno K, et al. Wnt3a stimulates maturation of impaired neutrophils developed from severe congenital neutropenia patient-derived pluripotent stem cells. Proc Natl Acad Sci U S A. 2013;110:3023–8.CrossRefPubMedPubMedCentral Hiramoto T, Ebihara Y, Mizoguchi Y, Nakamura K, Yamaguchi K, Ueno K, et al. Wnt3a stimulates maturation of impaired neutrophils developed from severe congenital neutropenia patient-derived pluripotent stem cells. Proc Natl Acad Sci U S A. 2013;110:3023–8.CrossRefPubMedPubMedCentral
15.
go back to reference Nayak RC, Trump LR, Aronow BJ, Myers K, Mehta P, Kalfa T, et al. Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells. J Clin Invest. 2015;125:3103–16.CrossRefPubMedPubMedCentral Nayak RC, Trump LR, Aronow BJ, Myers K, Mehta P, Kalfa T, et al. Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells. J Clin Invest. 2015;125:3103–16.CrossRefPubMedPubMedCentral
16.
go back to reference Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRefPubMed Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRefPubMed
17.
go back to reference Xia J, Bolyard AA, Rodger E, Stein S, Aprikyan AA, Dale DC, et al. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia. Br J Haematol. 2009;147:535–42.CrossRefPubMedPubMedCentral Xia J, Bolyard AA, Rodger E, Stein S, Aprikyan AA, Dale DC, et al. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia. Br J Haematol. 2009;147:535–42.CrossRefPubMedPubMedCentral
18.
19.
go back to reference Germeshausen M, Ballmaier M, Welte K. Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey. Blood. 2007;109:93–9.CrossRefPubMed Germeshausen M, Ballmaier M, Welte K. Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey. Blood. 2007;109:93–9.CrossRefPubMed
20.
go back to reference Germeshausen M, Schulze H, Ballmaier M, Zeidler C, Welte K. Mutations in the gene encoding neutrophil elastase (ELA2) are not sufficient to cause the phenotype of congenital neutropenia. Br J Haematol. 2001;115:222–4.CrossRefPubMed Germeshausen M, Schulze H, Ballmaier M, Zeidler C, Welte K. Mutations in the gene encoding neutrophil elastase (ELA2) are not sufficient to cause the phenotype of congenital neutropenia. Br J Haematol. 2001;115:222–4.CrossRefPubMed
21.
go back to reference Ancliff PJ, Gale RE, Watts MJ, Liesner R, Hann IM, Strobel S, et al. Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. Blood. 2002;100:707–9.CrossRefPubMed Ancliff PJ, Gale RE, Watts MJ, Liesner R, Hann IM, Strobel S, et al. Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. Blood. 2002;100:707–9.CrossRefPubMed
22.
go back to reference Kim HJ, Song MJ, Lee KO, Kim SH, Kim HJ. Paternal somatic mosaicism of a novel frameshift mutation in ELANE causing severe congenital neutropenia. Pediatr Blood Cancer. 2015;62:2229–31.CrossRefPubMed Kim HJ, Song MJ, Lee KO, Kim SH, Kim HJ. Paternal somatic mosaicism of a novel frameshift mutation in ELANE causing severe congenital neutropenia. Pediatr Blood Cancer. 2015;62:2229–31.CrossRefPubMed
23.
go back to reference Hirata O, Okada S, Tsumura M, Karakawa S, Matsumura I, Kimura Y, et al. Mosaicism of an ELANE mutation in an asymptomatic mother in a familial case of cyclic neutropenia. J Clin Immunol. 2015;35:512–6.CrossRefPubMed Hirata O, Okada S, Tsumura M, Karakawa S, Matsumura I, Kimura Y, et al. Mosaicism of an ELANE mutation in an asymptomatic mother in a familial case of cyclic neutropenia. J Clin Immunol. 2015;35:512–6.CrossRefPubMed
Metadata
Title
Mosaicism of an ELANE Mutation in an Asymptomatic Mother
Authors
Tomonari Shigemura
Norimoto Kobayashi
Kazunaga Agematsu
Osamu Ohara
Yozo Nakazawa
Publication date
01-01-2019
Publisher
Springer US
Keyword
Neutropenia
Published in
Journal of Clinical Immunology / Issue 1/2019
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-018-0580-1

Other articles of this Issue 1/2019

Journal of Clinical Immunology 1/2019 Go to the issue